Attachment 2. Extract from the Clinical Evaluation Report ...

Based on a review of quality, safety and efficacy, TGA approved the registration of Eltroxin, Aspen thyroxine and Thyroxine Aspen tablets, containing levothyroxine sodium; 25, 50, 75, 88, 100, 112, 125, 137, 150, 175 and 200 µg, for oral administration, indicated for: ................
................